176 related articles for article (PubMed ID: 12940437)
1. Contrasting action of IL-12 and IL-18 in the development of dextran sodium sulphate colitis in mice.
Takagi H; Kanai T; Okazawa A; Kishi Y; Sato T; Takaishi H; Inoue N; Ogata H; Iwao Y; Hoshino K; Takeda K; Akira S; Watanabe M; Ishii H; Hibi T
Scand J Gastroenterol; 2003 Aug; 38(8):837-44. PubMed ID: 12940437
[TBL] [Abstract][Full Text] [Related]
2. Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-gamma and TNF-alpha production.
Siegmund B; Fantuzzi G; Rieder F; Gamboni-Robertson F; Lehr HA; Hartmann G; Dinarello CA; Endres S; Eigler A
Am J Physiol Regul Integr Comp Physiol; 2001 Oct; 281(4):R1264-73. PubMed ID: 11557635
[TBL] [Abstract][Full Text] [Related]
3. Role of interleukin 15 in colitis induced by dextran sulphate sodium in mice.
Yoshihara K; Yajima T; Kubo C; Yoshikai Y
Gut; 2006 Mar; 55(3):334-41. PubMed ID: 16162679
[TBL] [Abstract][Full Text] [Related]
4. [Expression and function of interleukin-18 in mouse dextran sulfate sodium colitis].
Wen ZH; Quyang Q; Zhang H; Yi ZH; Wang YF
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Sep; 36(5):676-8. PubMed ID: 16235535
[TBL] [Abstract][Full Text] [Related]
5. Oral administration of bovine milk from cows hyperimmunized with intestinal bacterin stimulates lamina propria T lymphocytes to produce Th1-biased cytokines in mice.
Wang Y; Lin L; Yin C; Othtani S; Aoyama K; Lu C; Sun X; Yoshikai Y
Int J Mol Sci; 2014 Mar; 15(4):5458-71. PubMed ID: 24686517
[TBL] [Abstract][Full Text] [Related]
6. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice.
Dieleman LA; Ridwan BU; Tennyson GS; Beagley KW; Bucy RP; Elson CO
Gastroenterology; 1994 Dec; 107(6):1643-52. PubMed ID: 7958674
[TBL] [Abstract][Full Text] [Related]
7. In vivo treatment with a nonapeptide thymic hormone, facteur thymique serique (FTS), ameliorates chronic colitis induced by dextran sulphate sodium in mice.
Sun X; Yamada H; Yoshihara K; Awaya A; Yoshikai Y
Int Immunopharmacol; 2007 Jul; 7(7):928-36. PubMed ID: 17499195
[TBL] [Abstract][Full Text] [Related]
8. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines.
Dieleman LA; Palmen MJ; Akol H; Bloemena E; Peña AS; Meuwissen SG; Van Rees EP
Clin Exp Immunol; 1998 Dec; 114(3):385-91. PubMed ID: 9844047
[TBL] [Abstract][Full Text] [Related]
9. Suppressor of cytokine signaling-1 ameliorates dextran sulfate sodium-induced colitis in mice.
Horino J; Fujimoto M; Terabe F; Serada S; Takahashi T; Soma Y; Tanaka K; Chinen T; Yoshimura A; Nomura S; Kawase I; Hayashi N; Kishimoto T; Naka T
Int Immunol; 2008 Jun; 20(6):753-62. PubMed ID: 18381351
[TBL] [Abstract][Full Text] [Related]
10. Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice.
Ito R; Shin-Ya M; Kishida T; Urano A; Takada R; Sakagami J; Imanishi J; Kita M; Ueda Y; Iwakura Y; Kataoka K; Okanoue T; Mazda O
Clin Exp Immunol; 2006 Nov; 146(2):330-8. PubMed ID: 17034586
[TBL] [Abstract][Full Text] [Related]
11. IL-33 alleviates DSS-induced chronic colitis in C57BL/6 mice colon lamina propria by suppressing Th17 cell response as well as Th1 cell response.
Zhu J; Wang Y; Yang F; Sang L; Zhai J; Li S; Li Y; Wang D; Lu C; Sun X
Int Immunopharmacol; 2015 Dec; 29(2):846-853. PubMed ID: 26359542
[TBL] [Abstract][Full Text] [Related]
12. The ICE inhibitor pralnacasan prevents DSS-induced colitis in C57BL/6 mice and suppresses IP-10 mRNA but not TNF-alpha mRNA expression.
Bauer C; Loher F; Dauer M; Mayer C; Lehr HA; Schönharting M; Hallwachs R; Endres S; Eigler A
Dig Dis Sci; 2007 Jul; 52(7):1642-52. PubMed ID: 17393315
[TBL] [Abstract][Full Text] [Related]
13. Contrasting activity of cytosin-guanosin dinucleotide oligonucleotides in mice with experimental colitis.
Obermeier F; Dunger N; Strauch UG; Grunwald N; Herfarth H; Schölmerich J; Falk W
Clin Exp Immunol; 2003 Nov; 134(2):217-24. PubMed ID: 14616780
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter hepaticus-induced colitis in interleukin-10-deficient mice: cytokine requirements for the induction and maintenance of intestinal inflammation.
Kullberg MC; Rothfuchs AG; Jankovic D; Caspar P; Wynn TA; Gorelick PL; Cheever AW; Sher A
Infect Immun; 2001 Jul; 69(7):4232-41. PubMed ID: 11401959
[TBL] [Abstract][Full Text] [Related]
15. Exogenous administration of mesenchymal stem cells ameliorates dextran sulfate sodium-induced colitis via anti-inflammatory action in damaged tissue in rats.
Tanaka F; Tominaga K; Ochi M; Tanigawa T; Watanabe T; Fujiwara Y; Ohta K; Oshitani N; Higuchi K; Arakawa T
Life Sci; 2008 Dec; 83(23-24):771-9. PubMed ID: 18950645
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury.
Froicu M; Cantorna MT
BMC Immunol; 2007 Mar; 8():5. PubMed ID: 17397543
[TBL] [Abstract][Full Text] [Related]
17. Wuchereria bancrofti macrophage migration inhibitory factor-2 (rWbaMIF-2) ameliorates experimental colitis.
Ramani S; Chauhan N; Khatri V; Vitali C; Kalyanasundaram R
Parasite Immunol; 2020 Apr; 42(4):e12698. PubMed ID: 31976564
[TBL] [Abstract][Full Text] [Related]
18. Berberine ameliorates chronic relapsing dextran sulfate sodium-induced colitis in C57BL/6 mice by suppressing Th17 responses.
Li YH; Xiao HT; Hu DD; Fatima S; Lin CY; Mu HX; Lee NP; Bian ZX
Pharmacol Res; 2016 Aug; 110():227-239. PubMed ID: 26969793
[TBL] [Abstract][Full Text] [Related]
19. Larval Echinococcus multilocularis infection reduces dextran sulphate sodium-induced colitis in mice by attenuating T helper type 1/type 17-mediated immune reactions.
Wang J; Goepfert C; Mueller N; Piersigilli A; Lin R; Wen H; Vuitton DA; Vuitton L; Mueller C; Gottstein B
Immunology; 2018 May; 154(1):76-88. PubMed ID: 29121394
[TBL] [Abstract][Full Text] [Related]
20. In vivo treatment with the herbal phenylethanoid acteoside ameliorates intestinal inflammation in dextran sulphate sodium-induced colitis.
Hausmann M; Obermeier F; Paper DH; Balan K; Dunger N; Menzel K; Falk W; Schoelmerich J; Herfarth H; Rogler G
Clin Exp Immunol; 2007 May; 148(2):373-81. PubMed ID: 17437425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
